Piramal Pharma Limited Schedules Conference Call for Q1 FY2027 Earnings Discussion
Piramal Pharma Limited will host an investor and analyst conference call on July 30, 2026, to discuss its Q1 FY2027 results. The event is scheduled from 9:30 AM IST.The company has provided comprehensive dial-in details for investors across multiple time zones to attend the Q1 FY2027 Earnings Conference Call.
| Event | Location & Time | Telephone Number |
|---|---|---|
| Conference call on 30th July 2026 | India - 09:30 AM IST | +91 22 6280 1461 / +91 22 7115 8320 (Primary Number) |
| Conference call on 30th July 2026 | India - 09:30 AM IST | 1 800 120 1221 (Toll free number) |
| Conference call on 30th July 2026 | USA - 12:00 AM (Eastern Time - New York) | Toll free number 18667462133 |
| Conference call on 30th July 2026 | UK - 05:00 AM (London Time) | Toll free number 08081011573 |
| Conference call on 30th July 2026 | Singapore - 12:00 PM (Singapore Time) | Toll free number 8001012045 |
| Conference call on 30th July 2026 | Hong Kong - 12:00 PM (Hong Kong Time) | Toll free number 800964448 |
Piramal Pharma Limited offers a diverse portfolio of differentiated products and services supported by 17 global development and manufacturing facilities and a global distribution network spanning over 100 countries.
The company's business structure includes Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), which focuses on the complex hospital generics segment; and the Piramal Consumer Healthcare business, responsible for selling consumer and wellness products that are over-the-counter.
Additionally, one of PPL's associate companies, Abbvie Therapeutics India Private Limited, functions as a joint venture between Abbvie and PPL and has become a market leader in the ophthalmology therapy area within the Indian pharma market. Furthermore, PPL holds a strategic minority investment in Yapan Bio Private Limited, which operates in the biologics/bio-therapeutics and vaccine segments.
PPLPHARMA Stock Price Movement
As of 1:06 PM, Piramal Pharma Limited shares are slipping by 0.08% in live trading, currently valued at ₹179.28. The equity registered a slight decrease of ₹0.14 as over 3 million shares traded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.